{"id":134983,"date":"2026-09-23T10:00:58","date_gmt":"2026-09-23T10:00:58","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/134983\/"},"modified":"2026-09-23T10:00:58","modified_gmt":"2026-09-23T10:00:58","slug":"essilorluxottica-societe-anonyme-enxtpael-following-ubs-luxury-conference-is-the-growth-story-mispriced","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/134983\/","title":{"rendered":"EssilorLuxottica Soci\u00e9t\u00e9 Anonyme (ENXTPA:EL) Following UBS Luxury Conference Is The Growth Story Mispriced"},"content":{"rendered":"\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">EssilorLuxottica Soci\u00e9t\u00e9 anonyme (ENXTPA:EL) took the stage at the 2026 UBS Luxury Conference on 16 September, presenting its eyewear and vision care portfolio to a luxury-focused investor audience.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">The UBS Luxury Conference appearance comes after a tough stretch for EssilorLuxottica Soci\u00e9t\u00e9 anonyme&#8217;s shareholders, with the stock at \u20ac144.5 and the year to date share price return down 45.57%, contributing to a 46.10% decline in 1-year total shareholder return even as shorter term selling pressure has eased slightly in recent sessions.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Compare EssilorLuxottica Soci\u00e9t\u00e9 anonyme&#8217;s current pressure with other potential recovery stories by scanning our handpicked <a href=\"https:\/\/simplywall.st\/discover\/investing-ideas\/473076\/high-quality-undervalued-stocks\/global?utm_medium=finance_user&amp;utm_campaign=cta_screener_undervalued&amp;utm_source=yahoo&amp;blueprint=4761215\" data-ylk=\"slk:173%20high%20quality%20undervalued%20stocks;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;173 high quality undervalued stocks&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">173 high quality undervalued stocks<\/a> list that combines solid cash flows with stronger balance sheets.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">EssilorLuxottica Soci\u00e9t\u00e9 anonyme runs a broad, profitable eyewear and vision care platform, yet the share price has retreated sharply this year. Does that gap signal a fair reset or a mispriced global leader hiding in plain sight?  <\/p>\n<p>        Most Popular Narrative: 40% Undervalued          <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">EssilorLuxottica Soci\u00e9t\u00e9 anonyme closed at \u20ac144.5, while the most followed fair value narrative sits at about \u20ac242.65, implying a sizeable valuation gap that hinges on how convincingly the business can translate its expansion and product pipeline into future earnings.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Strong pipeline of innovation in myopia management solutions (Stellest 2.0, DOT technology) and leadership in addressing rising vision disorders among children globally positions EssilorLuxottica to capture outsized growth from increasing myopia incidence, directly supporting future revenue and market share gains.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">See why <a href=\"https:\/\/www.simplywall.st\/narratives\/07d0n8dv-el-expansion-into-new-optical-markets-will-drive-measured-medtech-momentum?utm_medium=finance_user&amp;utm_campaign=cta_narrative_prompt_after_quote&amp;utm_source=yahoo\" data-ylk=\"slk:37%20investors%20see%20EssilorLuxottica%20Soci%C3%A9t%C3%A9%20anonyme%20as%2040%25%20undervalued;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;37 investors see EssilorLuxottica Soci\u00e9t\u00e9 anonyme as 40% undervalued&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">37 investors see EssilorLuxottica Soci\u00e9t\u00e9 anonyme as 40% undervalued<\/a>.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Result: Fair Value of \u20ac242.65 (UNDERVALUED)  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Still, the EssilorLuxottica Soci\u00e9t\u00e9 anonyme story can be knocked off course if smart eyewear adoption lags expectations or if tariff and inflation pressures keep squeezing margins.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Find out about the <a href=\"https:\/\/www.simplywall.st\/company\/id\/3e57b646-63eb-4faf-8234-e59b6412383b?utm_medium=finance_user&amp;utm_campaign=risks_narrative_cta&amp;utm_source=yahoo\" data-ylk=\"slk:key%20risks%20to%20this%20EssilorLuxottica%20Soci%C3%A9t%C3%A9%20anonyme%20narrative;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;key risks to this EssilorLuxottica Soci\u00e9t\u00e9 anonyme narrative&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">key risks to this EssilorLuxottica Soci\u00e9t\u00e9 anonyme narrative<\/a>.  <\/p>\n<p>        Another View on EssilorLuxottica Soci\u00e9t\u00e9 anonyme&#8217;s Valuation          <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">The fair value narrative leans heavily on future earnings power, yet the current P\/E of 26.6x tells a different story. EssilorLuxottica Soci\u00e9t\u00e9 anonyme trades close to the European Medical Equipment average of 26.7x and below the peer group at 34.8x, while the fair ratio of 24.4x signals some valuation stretch.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">This combination of slight expensiveness relative to the fair ratio and lower levels versus peers raises a simple question for you: is this a quality stock priced for a modest reset, or a premium that still needs more earnings proof before it re-rates?  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\"><a href=\"https:\/\/www.simplywall.st\/company\/id\/3e57b646-63eb-4faf-8234-e59b6412383b\/valuation?utm_medium=finance_user&amp;utm_campaign=alternate_preferred_multiple_cta&amp;utm_source=yahoo\" data-ylk=\"slk:See%20what%20the%20numbers%20say%20about%20this%20price%20%E2%80%94%20find%20out%20in%20our%20valuation%20breakdown.;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;See what the numbers say about this price \u2014 find out in our valuation breakdown.&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">See what the numbers say about this price \u2014 find out in our valuation breakdown.<\/a>  <\/p>\n<p>   <a href=\"https:\/\/www.simplywall.st\/company\/id\/3e57b646-63eb-4faf-8234-e59b6412383b\/valuation?utm_medium=finance_user&amp;utm_campaign=infographic&amp;utm_source=yahoo\" target=\"_blank\" rel=\"noopener noreferrer nofollow\"><img loading=\"lazy\" decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/ywAAAAAAQABAAACAUwAOw==\" alt=\"ENXTPA:EL P\/E Ratio as at Sep 2026\" height=\"380\" width=\"960\" class=\"yf-1f8hkhu loader\"\/><\/a> ENXTPA:EL P\/E Ratio as at Sep 2026          Next Steps         <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Sentiment around EssilorLuxottica Soci\u00e9t\u00e9 anonyme is clearly split, with clear risks on one side and meaningful potential rewards on the other. Act quickly, review the data for yourself, then weigh up the <a href=\"https:\/\/www.simplywall.st\/stocks\/fr\/healthcare\/epa-el\/essilorluxottica-societe-anonyme-shares?utm_medium=finance_user&amp;utm_campaign=cta_risks_rewards_analysis&amp;utm_source=yahoo\" data-ylk=\"slk:3%20key%20rewards%20and%201%20important%20warning%20sign;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;3 key rewards and 1 important warning sign&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">3 key rewards and 1 important warning sign<\/a>.  <\/p>\n<p>       Looking for more investment ideas beyond EssilorLuxottica Soci\u00e9t\u00e9 anonyme?         <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Do not stop with a single stock. Use broader idea lists to pressure test your thesis, spot fresh angles, and keep your watchlist genuinely competitive.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Companies discussed in this article include <a href=\"https:\/\/finance.yahoo.com\/quote\/EL.PA\" data-ylk=\"slk:EL.PA;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;EL.PA&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"nofollow noopener\">EL.PA<\/a>.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Have feedback on this article? Concerned about the content? <a href=\"https:\/\/investor-research.typeform.com\/to\/wvg6MFri#feedback_token=NDc2MTIxNTowNjg3NWIzYTNkMTBjNDQ3&amp;company=ENXTPA:EL&amp;blueprintid=4761215\" data-ylk=\"slk:Get%20in%20touch;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;Get in touch&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Get in touch<\/a> with us directly. Alternatively, email <a href=\"https:\/\/ca.finance.yahoo.com\/news\/mailto:editorial-team@simplywallst.com?subject=Re%3A%20Your%20article%20on%20ENXTPA%3AEL%20(yahoo)%20from%2023rd%20September%202026\" data-ylk=\"slk:editorial-team%40simplywallst.com;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;editorial-team@simplywallst.com&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">editorial-team@simplywallst.com<\/a>  <\/p>\n","protected":false},"excerpt":{"rendered":"EssilorLuxottica Soci\u00e9t\u00e9 anonyme (ENXTPA:EL) took the stage at the 2026 UBS Luxury Conference on 16 September, presenting its&hellip;\n","protected":false},"author":2,"featured_media":134984,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[129],"tags":[65166,1104,65165,223],"class_list":["post-134983","post","type-post","status-publish","format-standard","has-post-thumbnail","category-ubs","tag-essilorluxottica","tag-fair-value","tag-societe-anonyme","tag-ubs"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/117319780444612340","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/134983","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=134983"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/134983\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/134984"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=134983"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=134983"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=134983"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}